Results of ACCURACY: A phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notch mut )
Ferrarotto, Renata, Metcalf, Robert, Rodriguez, Cristina P., Muzaffar, Jameel, Even, Caroline, Perez, Cesar Augusto, Van Herpen, Carla M.L.-, Oliva, Marc, Xia, Bing, Bowles, Daniel W., Popovtzer, Aharon, Winquist, Eric, Wirth, Lori J., Hao, Desiree, Kang, Hyunseok, Hotte, Sebastien J., Stemmer, Salomon M., Mehra, Ranee, Worden, Francis P., Ho, Alan Loh
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer
Chung, Christine H., Colevas, A. Dimitrios, Adkins, Douglas, Gibson, Michael K., Rodriguez, Cristina P., Sukari, Ammar, Bauman, Julie E., Wirth, Lori J., Johnson, Faye M., Saba, Nabil F., Burtness, Barbara, Dunn, Lara, Seiwert, Tanguy Y., Worden, Francis P., Muzaffar, Jameel, Margossian, Steven, Moniz, Raymond, Quayle, Steven N, Levisetti, Matteo, Pai, Sara I.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC): Results of a multicenter phase II international thyroid oncology group trial
Haugen, Bryan, French, Jena, Worden, Francis P., Konda, Bhavana, Sherman, Eric Jeffrey, Dadu, Ramona, Gianoukakis, Andrew G., Wolfe, Eric G., Foster, Nathan R., Bowles, Daniel W., Wirth, Lori J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma
Kang, Hyunseok, Ho, Alan Loh, Muzaffar, Jameel, Bowles, Daniel W., Kim, Sung-Bae, Ahn, Myung-Ju, Hanna, Glenn J., Worden, Francis P., Yun, Tak, Norton, Steven, Sankar, Neil, Keam, Bhumsuk
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Vismodegib (V) for organ preservation for locally advanced (LA) orbital/periocular basal cell carcinoma (BCC)
Worden, Francis P., Unsworth, Shelby A, Andrews, Chris A, Chan, May, Bresler, Scott, Bichakjian, Christopher Keram, Durham, Alison Bates, Demirci, Hakan, Elner, Victor, Nelson, Christine, Kim, Denise, Joseph, Shannon, Swiecicki, Paul, Kahana, Alon
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A randomized phase II network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Kochanny, Sara, Worden, Francis. P., Adkins, Douglas, Lim, Dean, Bauman, Julie E., Wagner, Stephanie A., Brisson, Ryan J., Karrison, Theodore, Stadler, Walter M., Vokes, Everett E., Seiwert, Tanguy Y.
Published in Cancer (19.02.2020)
Published in Cancer (19.02.2020)
Get full text
Journal Article
Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC)
Wise-Draper, Trisha Michel, Takiar, Vinita, Mierzwa, Michelle Lynn, Casper, Keith, Palackdharry, Sarah, Worden, Francis P., Old, Matthew O., Dunlap, Neal E., Kaczmar, John M., Patil, Yash, Riaz, Muhammad Kashif Kashif, Hamilton, Aubrey, Gillenwater, Ann M., Hinrichs, Benjamin H, Bell, Diana, Allen, Casey, Lanverman, Sheena M, Zhang, Li, Lee, J. Jack, Gillison, Maura L.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Palbociclib (P) in patients (pts) with head and neck cancer (HNC) with CDKN2A loss or mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study
Pisick, Evan P., Rothe, Michael, Mangat, Pam K., Garrett-Mayer, Liz, Worden, Francis P., Bauman, Jessica R., Fu, Siqing, Leidner, Rom S., Balmanoukian, Ani Sarkis, Calfa, Carmen, Carrizosa, Daniel R., D'Andre, Stacy D., Nabell, Lisle, Park, Min S., Powell, Steven Francis, Thota, Ramya, Schilsky, Richard L.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Sinonasal Undifferentiated Carcinoma: A 13-Year Experience at a Single Institution
Lin, Erin M, Sparano, Anthony, Spalding, Aaron, Eisbruch, Avraham, Worden, Francis P, Heth, Jason, Sullivan, Stephen E, Thompson, B. Gregory, Marentette, Lawrence J
Published in Skull base (01.03.2010)
Published in Skull base (01.03.2010)
Get full text
Journal Article
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer
Rosenberg, A.J., Liao, C.-Y., Karrison, T., de Souza, J.A., Worden, F.P., Libao, B., Krzyzanowska, M.K., Hayes, D.N., Winquist, E., Saloura, V., Prescott, K., Villaflor, V.M., Seiwert, T.Y., Schechter, R.B., Stadler, W.M., Cohen, E.E.W., Vokes, E.E.
Published in Annals of oncology (01.08.2023)
Published in Annals of oncology (01.08.2023)
Get full text
Journal Article
Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers
Ho, Alan Loh, Foster, Nathan R., Zoroufy, Alexander J., Worden, Francis P., Price, Katharine Andress Rowe, Adkins, Douglas, Bowles, Daniel W., Kang, Hyunseok, Burtness, Barbara, Sherman, Eric Jeffrey, Morton, Roscoe F., Katabi, Nora, Munster, Pamela N., Schwartz, Gary K.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
An open label, nonrandomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of cohort 1 interim analysis
Sacco, Assuntina Gesualda, Chen, Ruifeng, Ghosh, Debanjali, Wong, Deborah J.L., Worden, Francis P., Adkins, Douglas, Pittman, Emily, Messer, Karen, Gold, Kathryn A., Daniels, Gregory A., Swiecicki, Paul, Sutton, Brian, Natsuhara, Amanda, Cohen, Ezra E.W.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Abstract 3418: A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: The salivary gland tumor cohort
Chae, Young Kwang, Othus, Megan, Patel, Sandip Pravin, Ohr, James P., Worden, Francis P., Suga, Jennifer M., Naing, Aung, Fenton, Sarah E., Kang, Hyunseok, Gurung, Sewan, McLeod, Christine M., Giles, Francis J., Chen, Helen X., Sharon, Elad, Mayerson, Edward, Plets, Melissa, Ryan, Christopher, Blanke, Charles D., Kurzrock, Razelle
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Selpercatinib (LOXO-292) in patients with RET -mutant medullary thyroid cancer
Shah, Manisha H., Sherman, Eric Jeffrey, Robinson, Bruce, Solomon, Benjamin J., Kang, Hyunseok, Lorch, Jochen H., Worden, Francis P., Brose, Marcia S., Leboulleux, Sophie, Godbert, Yann, Meurer, Marie, Morris, John C., Owonikoko, Taofeek Kunle, Tan, Daniel Shao-Weng, Gautschi, Oliver, Patel, Jyoti D., Yang, Luxi, Kherani, Jennifer, Cabanillas, Maria E., Wirth, Lori J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of the interim safety analysis
Sacco, Assuntina Gesualda, Messer, Karen, Natsuhara, Amanda, Chen, Ruifeng, Wong, Deborah J.L., Worden, Francis P., Adkins, Douglas, Pittman, Emily, Zhang, Jing, Daniels, Gregory A., Gold, Kathryn A., Espiritu, Maechelle, Sutton, Brian, Cohen, Ezra E.W.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Multicenter phase II trial of palbociclib, a selective cyclin dependent kinase (CDK) 4/6 inhibitor, and cetuximab in platinum-resistant HPV unrelated (-) recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC)
Adkins, Douglas, Oppelt, Peter John, Ley, Jessica C., Trinkaus, Kathryn, Neupane, Prakash C., Sacco, Assuntina Gesualda, Palka, Kevin A, Worden, Francis P., Grilley-Olson, Juneko E., Maggiore, Ronald John, Steuer, Conor Ernst, Saba, Nabil F.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Trends in Imaging after Thyroid Cancer Diagnosis
Wiebel, Jaime, Banerjee, Mousumi, Muenz, Daniel G., Worden, Francis P., Haymart, Megan R.
Published in Cancer (06.01.2015)
Published in Cancer (06.01.2015)
Get full text
Journal Article
Association of low neutrophil-to-lymphocyte ratios (NLR) and high lymphocyte-to-monocyte ratios (LMR) with overall survival and response to induction chemotherapy (IC) when used to select patients (pts) with locally advanced squamous cell of the larynx (LSCC) for combined chemoradiation (CRT)
Risch, Zachary, Bellile, Emily, Townsend, Ryan, Swiecicki, Paul, Casper, Keith, Malloy, Kelly M, Hogikyan, Norman D, Spector, Matthew E, Shuman, Andrew, Stucken, Chaz, Chinn, Steven Bennett, Chepeha, Douglas Brian, Jolly, Shruti, Mierzwa, Michelle Lynn, Bradford, Carol Rossier, Eisbruch, Avraham, Carey, Thomas E., Prince, Mark E, Wolf, Gregory T., Worden, Francis P.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
A randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor
Swiecicki, Paul, Bellile, Emily, Casper, Keith, Malloy, Kelly M, Kupfer, Robbi, Spector, Matthew E, Shuman, Andrew, Chinn, Steven Bennett, Stucken, Chaz, Srinivasan, Ashok, Owen, Dawn, Dragovic, Aleksandar Filip, Mierzwa, Michelle, Jolly, Shruti, Bradford, Carol Rossier, Eisbruch, Avraham, Carey, Thomas E., Prince, Mark E, Wolf, Gregory T., Worden, Francis P.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article